Pfizer’s COVID-19 vaccine announcement was a shot in the arm for three of our Growth Portfolio holdings. Read More

The economy should fully reopen in the months to come, but some businesses will benefit more than others. Read More

You Have Questions, We Have Answers Read More

Prospects of a new president and a trio of coronavirus vaccines sent stocks soaring. Read More

Despite its noisy aftermath, the election is over. Investors should position their portfolios for the inevitable transfer of power. Read More

Since the November 3 election, HIMX has rallied 65% to trade above $6 for the first time in over two years. Read More

Many financial advisors today miss the boat when they omit this crucial asset class from their advice. Read More

These three sectors offer high yields and capital appreciation potential as the economy gradually reopens. Read More

Homebound shoppers are getting packages delivered in record numbers. Read More